DNA damage and repair in atherosclerosis: Current insights and future perspectives

International Journal of Molecular Sciences

Volumn 13, Issue 12, 2012, Pages 16929-16944

  Cervelli, Tiziana ^a   Borghini, Andrea ^a   Galli, Alvaro ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; DNA damage; DNA repair; MiRNAs

Indexed keywords

MICRORNA; SIMVASTATIN;

ATHEROSCLEROSIS; BASE MISPAIRING; DNA ADDUCT; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; CELL CYCLE CHECKPOINT; METABOLISM; PATHOLOGY;

APOPTOSIS; ATHEROSCLEROSIS; CELL CYCLE CHECKPOINTS; DNA DAMAGE; DNA REPAIR; HUMANS; PLAQUE, ATHEROSCLEROTIC;

EID: 84871703774     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131216929     Document Type: Review

References (95)

1. Rosamond, W.; Flegal, K.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.M.; Ho, M.; Howard, V.; Kissela, B.; et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117, e25-e146.
2. Ross, R. Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am. J. Pathol. 1993, 143, 987-1002.
3. Andreassi, M.G. Metabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interaction. Mutat. Res. 2009, 667, 35-43.
4. Libby, P.; Ridker, P.M.; Hansson, G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473, 317-325.
5. Andreassi, M.G. DNA damage, vascular senescence and atherosclerosis. J. Mol. Med. (Berl.) 2008, 86, 1033-1043.
6. Wang, J.C.; Bennett, M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 2012, 111, 245-259.
7. Herbert, K.E.; Mistry, Y.; Hastings, R.; Poolman, T.; Niklason, L.; Williams, B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ. Res. 2008, 102, 201-208.
8. Izzotti, A.; Cartiglia, C.; Lewtas, J.; De Flora, S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 2001, 15, 752-757.
9. Andreassi, M.G.; Barale, R.; Iozzo, P.; Picano, E. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease. Mutagenesis 2011, 26, 77-83.
10. Kiaris, H.; Hatzistamou, J.; Spandidos, D.A. Instability at the H-ras minisatellite in human atherosclerotic plaques. Atherosclerosis 1996, 125, 47-51.
11. Hatzistamou, J.; Kiaris, H.; Ergazaki, M.; Spandidos, D.A. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem. Biophys. Res. Commun. 1996, 225, 186-190.
12. Spandidos, D.; Ergazaki, M.; Hatzistamou, J.; Kiaris, H.; Bouros, D.; Tzortzaki, E.; Siafakas, N. Microsatellite instability in patients with chronic obstructive pulmonary disease. Oncol. Rep. 1996, 3, 489-491.
13. McCaffrey, T.A.; Du, B.; Consigli, S.; Szabo, P.; Bray, P.J.; Hartner, L.; Weksler, B.B.; Sanborn, T.A.; Bergman, G.; Bush, H.L., Jr. Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest. 1997, 100, 2182-2188.
14. Casalone, R.; Granata, P.; Minelli, E.; Portentoso, P.; Giudici, A.; Righi, R.; Castelli, P.; Socrate, A.; Frigerio, B. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum. Genet. 1991, 87, 139-143.
15. Matturri, L.; Cazzullo, A.; Turconi, P.; Lavezzi, A.M. Cytogenetic aspects of cell proliferation in atherosclerotic plaques. Cardiologia 1997, 42, 833-836.
16. De Flora, S.; Izzotti, A.; Walsh, D.; Degan, P.; Petrilli, G.L.; Lewtas, J. Molecular epidemiology of atherosclerosis. FASEB J. 1997, 11, 1021-1031.
17. Izzotti, A.; Piana, A.; Minniti, G.; Vercelli, M.; Perrone, L.; de Flora, S. Survival of atherosclerotic patients as related to oxidative stress and gene polymorphisms. Mutat. Res. 2007, 621, 119-128.
18. Nair, J.; de Flora, S.; Izzotti, A.; Bartsch, H. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat. Res. 2007, 621, 95-105.
19. Demirbag, R.; Yilmaz, R.; Gur, M.; Kocyigit, A.; Celik, H.; Guzel, S.; Selek, S. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat. Res. 2005, 578, 298-307.
20. Federici, C.; Botto, N.; Manfredi, S.; Rizza, A.; del Fiandra, M.; Andreassi, M.G. Relation of increased chromosomal damage to future adverse cardiac events in patients with known coronary artery disease. Am. J. Cardiol. 2008, 102, 1296-1300.
21. Matthews, C.; Gorenne, I.; Scott, S.; Figg, N.; Kirkpatrick, P.; Ritchie, A.; Goddard, M.; Bennett, M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circ. Res. 2006, 99, 156-164.
22. Durik, M.; Kavousi, M.; van der Pluijm, I.; Isaacs, A.; Cheng, C.; Verdonk, K.; Loot, A.E.; Oeseburg, H.; Bhaggoe, U.M.; Leijten, F.; et al. Nucleotide excision DNA repair is associated with age-related vascular dysfunction. Circulation 2012, 126, 468-478.
23. Mahmoudi, M.; Gorenne, I.; Mercer, J.; Figg, N.; Littlewood, T.; Bennett, M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ. Res. 2008, 103, 717-725.
24. Mercer, J.R.; Cheng, K.K.; Figg, N.; Gorenne, I.; Mahmoudi, M.; Griffin, J.; Vidal-Puig, A.; Logan, A.; Murphy, M.P.; Bennett, M. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 2010, 107, 1021-1031.
25. Perez-Rivero, G.; Ruiz-Torres, M.P.; Rivas-Elena, J.V.; Jerkic, M.; Diez-Marques, M.L.; Lopez-Novoa, J.M.; Blasco, M.A.; Rodriguez-Puyol, D. Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation 2006, 114, 309-317.
26. Jeon, B.H.; Gupta, G.; Park, Y.C.; Qi, B.; Haile, A.; Khanday, F.A.; Liu, Y.X.; Kim, J.M.; Ozaki, M.; White, A.R.; et al. Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ. Res. 2004, 95, 902-910.
27. Friedberg, E.C.W.; Siede, G.C.; Wood, R.D.; Schultz, R.A.; Ellenberger, T. DNA Repair and Mutagenesis; ASM Press: Washington, DC, USA, 2006; pp. 4-5.
28. Cleaver, J.E.; Lam, E.T.; Revet, I. Disorders of nucleotide excision repair: The genetic and molecular basis of heterogeneity. Nat. Rev. Genet. 2009, 10, 756-768.
29. Krokan, H.E.; Standal, R.; Slupphaug, G. DNA glycosylases in the base excision repair of DNA. Biochem. J. 1997, 325, 1-16.
30. Luo, X.; Kraus, W.L. On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012, 26, 417-432.
31. Kalisch, T.; Ame, J.C.; Dantzer, F.; Schreiber, V. New readers and interpretations of poly(ADP-ribosyl)ation. Trends Biochem. Sci. 2012, 37, 381-390.
32. Virag, L.; Szabo, C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 2002, 54, 375-429.
33. Heyer, W.D.; Ehmsen, K.T.; Liu, J. Regulation of homologous recombination in eukaryotes. Annu. Rev. Genet. 2010, 44, 113-139.
34. Stracker, T.H.; Petrini, J.H. The MRE11 complex: Starting from the ends. Nat. Rev. Mol. Cell Biol. 2011, 12, 90-103.
35. Lieber, M.R.; Ma, Y.; Pannicke, U.; Schwarz, K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 2003, 4, 712-720.
36. Hoeijmakers, J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411, 366-374.
37. Chanoux, R.A.; Yin, B.; Urtishak, K.A.; Asare, A.; Bassing, C.H.; Brown, E.J. ATR and H2AX cooperate in maintaining genome stability under replication stress. J. Biol. Chem. 2009, 284, 5994-6003.
38. Huen, M.S.; Chen, J. The DNA damage response pathways: At the crossroad of protein modifications. Cell Res. 2008, 18, 8-16.
39. Pillarisetti, S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat. Cardiovasc. Drug Discov. 2008, 3, 156-164.
40. Zeng, L.; Chen, R.; Liang, F.; Tsuchiya, H.; Murai, H.; Nakahashi, T.; Iwai, K.; Takahashi, T.; Kanda, T.; Morimoto, S. Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr. Gerontol. Int. 2009, 9, 7-15.
41. Gorospe, M.; de Cabo, R. AsSIRTing the DNA damage response. Trends Cell Biol. 2008, 18, 77-83.
42. Yuan, Z.; Seto, E. A functional link between SIRT1 deacetylase and NBS1 in DNA damage response. Cell Cycle 2007, 6, 2869-2871.
43. Mao, Z.; Hine, C.; Tian, X.; van Meter, M.; Au, M.; Vaidya, A.; Seluanov, A.; Gorbunova, V. SIRT6 promotes DNA repair under stress by activating PARP1. Science 2011, 332, 1443-1446.
44. Mostoslavsky, R.; Chua, K.F.; Lombard, D.B.; Pang, W.W.; Fischer, M.R.; Gellon, L.; Liu, P.; Mostoslavsky, G.; Franco, S.; Murphy, M.M.; et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124, 315-329.
45. McCord, R.A.; Michishita, E.; Hong, T.; Berber, E.; Boxer, L.D.; Kusumoto, R.; Guan, S.; Shi, X.; Gozani, O.; Burlingame, A.L.; et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 2009, 1, 109-121.
46. Kaidi, A.; Weinert, B.T.; Choudhary, C.; Jackson, S.P. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010, 329, 1348-1353.
47. Shukla, P.C.; Singh, K.K.; Quan, A.; Al-Omran, M.; Teoh, H.; Lovren, F.; Cao, L.; Rovira, I.I.; Pan, Y.; Brezden-Masley, C.; et al. BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat. Commun. 2011, 2, doi:10.1038/ncomms1601.
48. Okuno, Y.; Nakamura-Ishizu, A.; Otsu, K.; Suda, T.; Kubota, Y. Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat. Med. 2012, 18, 1208-1216.
49. Pacher, P.; Szabo, C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug Rev. 2007, 25, 235-260.
50. Martinet, W.; Knaapen, M.W.; De Meyer, G.R.; Herman, A.G.; Kockx, M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002, 106, 927-932.
51. Benko, R.; Pacher, P.; Vaslin, A.; Kollai, M.; Szabo, C. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Life Sci. 2004, 75, 1255-1261.
52. Radovits, T.; Lin, L.N.; Zotkina, J.; Gero, D.; Szabo, C.; Karck, M.; Szabo, G. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro. Eur. J. Pharmacol. 2007, 564, 158-166.
53. Pernice, F.; Floccari, F.; Caccamo, C.; Belghity, N.; Mantuano, S.; Pacile, M.E.; Romeo, A.; Nostro, L.; Barilla, A.; Crasci, E.; et al. Chromosomal damage and atherosclerosis. A protective effect from simvastatin. Eur. J. Pharmacol. 2006, 532, 223-229.
54. Flouris, G.A.; Arvanitis, D.A.; Parissis, J.T.; Arvanitis, D.L.; Spandidos, D.A. Loss of heterozygosity in DNA mismatch repair genes in human atherosclerotic plaques. Mol. Cell Biol. Res. Commun. 2000, 4, 62-65.
55. Miniati, P.; Sourvinos, G.; Michalodimitrakis, M.; Spandidos, D.A. Loss of heterozygosity on chromosomes 1, 2, 8, 9 and 17 in cerebral atherosclerotic plaques. Int. J. Biol. Markers 2001, 16, 167-171.
56. Guo, Z.; Kozlov, S.; Lavin, M.F.; Person, M.D.; Paull, T.T. ATM activation by oxidative stress. Science 2010, 330, 517-521.
57. Alcendor, R.R.; Gao, S.; Zhai, P.; Zablocki, D.; Holle, E.; Yu, X.; Tian, B.; Wagner, T.; Vatner, S.F.; Sadoshima, J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007, 100, 1512-1521.
58. Zhang, Q.J.; Wang, Z.; Chen, H.Z.; Zhou, S.; Zheng, W.; Liu, G.; Wei, Y.S.; Cai, H.; Liu, D.P.; Liang, C.C. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 2008, 80, 191-199.
59. Tokunaga, O.; Fan, J.L.; Watanabe, T. Atherosclerosis-and age-related multinucleated variant endothelial cells in primary culture from human aorta. Am. J. Pathol. 1989, 135, 967-976.
60. Aviv, H.; Khan, M.Y.; Skurnick, J.; Okuda, K.; Kimura, M.; Gardner, J.; Priolo, L.; Aviv, A. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 2001, 159, 281-287.
61. Borradaile, N.M.; Pickering, J.G. Polyploidy impairs human aortic endothelial cell function and is prevented by nicotinamide phosphoribosyltransferase. Am. J. Physiol. Cell Physiol. 2010, 298, C66-C74.
62. Bazo, A.P.; Salvadori, D., Jr.; Salvadori, R.A.; Sodre, L.P.; da Silva, G.N.; de Camargo, E.A.; Ribeiro, L.R.; Salvadori, D.M. DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease. Cardiovasc. Pathol. 2011, 20, e9-e15.
63. Guven, M.; Guven, G.S.; Oz, E.; Ozaydin, A.; Batar, B.; Ulutin, T.; Hacihanefioglu, S.; Domanic, N. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 2007, 22, 355-360.
64. Mahmoudi, M.; Mercer, J.; Bennett, M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 2006, 71, 259-268.
65. Shyu, H.Y.; Shieh, J.C.; Ji-Ho, L.; Wang, H.W.; Cheng, C.W. Polymorphisms of DNA repair pathway genes and cigarette smoking in relation to susceptibility to large artery atherosclerotic stroke among ethnic Chinese in Taiwan. J. Atheroscler. Thromb. 2012, 19, 316-325.
66. Shimoyama, Y.; Mitsuda, Y.; Tsuruta, Y.; Suzuki, K.; Hamajima, N.; Niwa, T. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. J. Ren. Nutr. 2012, 22, 114-119.
67. Dong, C.; Della-Morte, D.; Wang, L.; Cabral, D.; Beecham, A.; McClendon, M.S.; Luca, C.C.; Blanton, S.H.; Sacco, R.L.; Rundek, T. Association of the sirtuin and mitochondrial uncoupling protein genes with carotid plaque. PLoS One 2011, 6, e27157.
68. Samani, N.J.; Schunkert, H. Chromosome 9p21 and cardiovascular disease: the story unfolds. Circ. Cardiovasc. Genet. 2008, 1, 81-84.
69. Visel, A.; Zhu, Y.; May, D.; Afzal, V.; Gong, E.; Attanasio, C.; Blow, M.J.; Cohen, J.C.; Rubin, E.M.; Pennacchio, L.A. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010, 464, 409-412.
70. Crippa, S.; Cassano, M.; Sampaolesi, M. Role of miRNAs in muscle stem cell biology: Proliferation, differentiation and death. Curr. Pharm. Des. 2012, 18, 1718-1729.
71. Karp, X.; Ambros, V. Developmental biology. Encountering microRNAs in cell fate signaling. Science 2005, 310, 1288-1289.
72. Miska, E.A.; Alvarez-Saavedra, E.; Townsend, M.; Yoshii, A.; Sestan, N.; Rakic, P.; Constantine-Paton, M.; Horvitz, H.R. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5, doi:10.1186/gb-2004-5-9-r68.
73. Xu, P.; Guo, M.; Hay, B.A. MicroRNAs and the regulation of cell death. Trends Genet. 2004, 20, 617-624.
74. Hu, H.; Gatti, R.A. MicroRNAs: New players in the DNA damage response. J. Mol. Cell Biol. 2011, 3, 151-158.
75. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215-233.
76. Ikeda, S.; Kong, S.W.; Lu, J.; Bisping, E.; Zhang, H.; Allen, P.D.; Golub, T.R.; Pieske, B.; Pu, W.T. Altered microRNA expression in human heart disease. Physiol. Genomics 2007, 31, 367-373.
77. Hartmann, D.; Thum, T. MicroRNAs and vascular (dys)function. Vascul. Pharmacol. 2011, 55, 92-105.
78. Thum, T. MicroRNA therapeutics in cardiovascular medicine. EMBO Mol. Med. 2012, 4, 3-14.
79. Hammond, S.M. RNAi, microRNAs, and human disease. Cancer Chemother. Pharmacol. 2006, 58, s63-s68.
80. Mann, D.L. MicroRNAs and the failing heart. N. Eng. J. Med. 2007, 356, 2644-2645.
81. Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C.; Weber, M.; Hamm, C.W.; Roxe, T.; Muller-Ardogan, M.; et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107, 677-684.
82. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107, 810-817.
83. Raitoharju, E.; Lyytikainen, L.P.; Levula, M.; Oksala, N.; Mennander, A.; Tarkka, M.; Klopp, N.; Illig, T.; Kahonen, M.; Karhunen, P.J.; et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219, 211-217.
84. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456, 980-984.
85. Wan, G.; Mathur, R.; Hu, X.; Zhang, X.; Lu, X. miRNA response to DNA damage. Trends Biochem. Sci. 2011, 36, 478-484.
86. Simone, N.L.; Soule, B.P.; Ly, D.; Saleh, A.D.; Savage, J.E.; Degraff, W.; Cook, J.; Harris, C.C.; Gius, D.; Mitchell, J.B. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 2009, 4, e6377.
87. Yu, Y.; Wang, Y.; Ren, X.; Tsuyada, A.; Li, A.; Liu, L.J.; Wang, S.E. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor beta contributes to chemoresistance in breast cancer cells. Mol. Cancer Res. 2010, 8, 1633-1642.
88. Lin, Y.; Liu, X.; Cheng, Y.; Yang, J.; Huo, Y.; Zhang, C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J. Biol. Chem. 2009, 284, 7903-7913.
89. Ito, T.; Yagi, S.; Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398, 735-740.
90. Jackson, S.P.; Bartek, J. The DNA-damage response in human biology and disease. Nature 2009, 461, 1071-1078.
91. Kobayashi, K.; Imanishi, T.; Akasaka, T. Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model. Hypertens. Res. 2006, 29, 449-455.
92. Imanishi, T.; Kobayashi, K.; Kuroi, A.; Mochizuki, S.; Goto, M.; Yoshida, K.; Akasaka, T. Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Hypertension 2006, 48, 1058-1065.
93. Oeseburg, H.; Iusuf, D.; van der Harst, P.; van Gilst, W.H.; Henning, R.H.; Roks, A.J. Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2009, 53, 417-422.
94. Addabbo, F.; Montagnani, M.; Goligorsky, M.S. Mitochondria and reactive oxygen species. Hypertension 2009, 53, 885-892.
95. Carafa, V.; Nebbioso, A.; Altucci, L. Sirtuins and disease: The road ahead. Front. Pharmacol. 2012, 3, doi:10.3389/fphar.2012.00004.